Heart failure associated with chronic Chagas cardiomyopathy increases the risk of impaired lung function and reduced submaximal functional capacity

dc.contributor.authorSilva, Patrício Braz da
dc.contributor.authorDiniz, Clara Pinto
dc.contributor.authorMediano, Mauro Felippe Felix
dc.contributor.authorMendes, Fernanda de Souza Nogueira Sardinha
dc.contributor.authorHasslocher-Moreno, Alejandro Marcel
dc.contributor.authorReis, Luís Felipe Fonseca
dc.contributor.authorReis, Michel Silva
dc.date.accessioned2025-12-16T16:35:08Z
dc.date.available2025-12-16T16:35:08Z
dc.date.issued2025
dc.description.abstractBackground: With the evolution of chronic Chagas cardiomyopathy (CC) and the progression towards heart failure (HF), patients may show a decline in inspiratory muscle strength, lung function, and functional capacity. Objective: We compared respiratory function and submaximal functional capacity in patients with CC with versus without HF. Methods: This observational, cross-sectional study was carried out with CC patients divided into CCG, a group without HF (n = 28), and HFG, a group with HF (n = 27). Spirometry (percent predicted forced vital capacity (ppFVC), forced expiratory volume in one second of FVC (ppFEV1), forced expiratory flow between 25 % and 75 % of FVC (ppFEF25-75%), and maximum voluntary ventilation (ppMVV)) and submaximal functional capacity (six-minute step test: 6MST) were evaluated. Mann-Whitney (comparison of pulmonary function and functional capacity between groups) and linear regression (association between the presence of HF and other variables) were performed. Results: We included 55 participants, with median age of 67 years (56.25-71.75) and 54.55 % males. Dyslipidemia was the most recurrent comorbidity (49.09 %). HFG presented lower ppFVC (P = 0.000), ppFEV1 (P = 0.011), ppFEF25-75% (P = 0.017), and ppMVV (P = 0.003) than the CCG. The ppFVC (B = -18.95; P = 0.000), ppFEV1 (B = -16.29; P = 0.021), ppFEF25-75% (B = -19.57; P = 0.014), ppMVV (B = -16.59; P = 0.003), and 6MST (B = -17.13; P = 0.034) were negatively associated with the presence of HF. Conclusion: Our data suggest that impaired lung function, compatible with a restrictive pulmonary pattern, is present among adults with CC and HF.
dc.identifier.citationSilva PB, Diniz CP, Mediano MFF, Mendes FSNS, Hasslocher-Moreno AM, Reis LFF, Reis MS, Saraiva RM, de Holanda MT, Mazzoli-Rocha F, de Sousa AS. Heart failure associated with chronic Chagas cardiomyopathy increases the risk of impaired lung function and reduced submaximal functional capacity. Heart Lung. 2025 Jan-Feb;69:222-228. doi: 10.1016/j.hrtlng.2024.10.009.
dc.identifier.otherDOI: 10.1016/j.hrtlng.2024.10.009
dc.identifier.urihttps://dspace.inc.saude.gov.br/handle/123456789/1049
dc.language.isoen
dc.publisherHeart & Lung
dc.titleHeart failure associated with chronic Chagas cardiomyopathy increases the risk of impaired lung function and reduced submaximal functional capacity
dc.title.alternativeA insuficiência cardíaca associada à cardiomiopatia chagásica crônica aumenta o risco de comprometimento da função pulmonar e redução da capacidade funcional submáxima
dc.typeArticle
Arquivos
Original bundle
Agora exibindo 1 - 1 de 1
thumbnail.default.alt
Nome:
Silva PB et al_Heart & Lung_2025.pdf
Tamanho:
1.1 MB
Formato:
Adobe Portable Document Format
Descrição:
License bundle
Agora exibindo 1 - 1 de 1
thumbnail.default.placeholder
Nome:
license.txt
Tamanho:
1.71 KB
Formato:
Item-specific license agreed to upon submission
Descrição: